--- title: Olaplex: the haircare brand that launched in salons before retail | RGM® url: https://realgrowthmatters.com/learn/case-studies/olaplex-bond-builder-launch/ updated: 2026-06-10 source_html: https://realgrowthmatters.com/learn/case-studies/olaplex-bond-builder-launch/ --- - **Story:** Olaplex launched in 2014 with patented bond-rebuilding hair technology used exclusively in professional salons. Stylist endorsements scaled the brand before retail expansion. Olaplex IPO'd in September 2021 at over $14 billion in valuation. Post-IPO stock performance has been brutal — by 2024 the stock had lost over 90% of peak value. - **Why it matters:** Olaplex is the structural model for professional-first beauty launches AND the cautionary example of post-IPO unit-economics collapse. The salon-first strategy worked; the IPO timing and post-IPO category-saturation dynamics produced one of the worst beauty-IPO trajectories in recent history. - **Takeaway:** Professional-first launches require product chemistry differentiated enough for professionals to verify in their work. - **Takeaway:** Stylist evangelism scales brands cheaply when the product genuinely works. - **Takeaway:** IPO timing matters more than IPO valuation. Pricing at the top of a category wave usually produces post-IPO challenges. ## Olaplex — the four-step story S Situation Prestige haircare was luxury positioning, not chemistry In 2013, prestige haircare was Kerastase, Bumble and bumble, Oribe — competing on luxury, fragrance, and packaging. Few products claimed transformative chemistry. The category was ready for genuine technological differentiation. T Task Launch through professionals before retail Olaplex had patented bond-rebuilding chemistry. The strategy was to use stylists as the proof point — let professionals verify the technology in their chairs before expanding to retail consumer awareness. A Action Salon-only 2014-2017, retail expansion via No. 3 Hair Perfector Launch exclusively in professional salons in 2014. Invest in stylist education and trade shows. Let stylist evangelism build credibility for three years. Launch No. 3 Hair Perfector at retail in 2017 with stylist-driven word-of-mouth pre-built. R Result $14B IPO in 2021, 90%+ stock decline by 2024 Olaplex grew significantly through 2014-2021 and IPO'd at over $14B valuation in September 2021. Post-IPO performance has been brutal — category saturation, distribution disruption, hair-loss lawsuits, and growth deceleration drove the stock down over 90% from peak by 2024. ## Olaplex at a glance 0 Founded Patent on bond-rebuilding chemistry Source: Olaplex company history 0 IPO year September 2021, NASDAQ: OLPX at $14B+ valuation Source: SEC S-1 $0B+ IPO peak valuation Day-one trading high Source: Public market data -0% Stock decline by 2024 From peak post-IPO trading Source: Public market data 0 Patented ingredient Bis-Aminopropyl Diglycol Dimaleate Source: Olaplex patent filings 0 yrs Pro-only before retail 2014-2017 professional channel before No. 3 Hair Perfector retail launch Source: Olaplex distribution history #### Quick facts CompanyOlaplex Holdings, Inc. (NASDAQ: OLPX) FounderDean Christal (CEO 2014-2020) Founded2014 TechnologyBis-Aminopropyl Diglycol Dimaleate (patented bond-rebuilding ingredient) Original distributionProfessional salons only (No. 1 and No. 2 in-salon treatments) Retail expansion~2017 (No. 3 Hair Perfector as the first retail product) IPOSeptember 2021 at $14B+ valuation Post-IPO stock decline~90%+ from peak by 2024 **Honest note** Olaplex is a public company (NASDAQ: OLPX) and disclosures are in SEC filings. The 2021 IPO at $14B+ valuation and the subsequent 90%+ stock decline are both well documented. The post-IPO performance reflects multiple factors including category-saturation as competitors entered, changing distribution dynamics, and lawsuits alleging product safety issues. The salon-first launch strategy remains the part most useful to study; the post-IPO trajectory is the cautionary half. ## Where prestige haircare was in 2013 In 2013, prestige haircare was dominated by Kerastase, Bumble and bumble, Oribe, and similar brands sold through salons and prestige retail (Sephora, Ulta). The category competed on luxury positioning, fragrance, and packaging. Few products claimed transformative chemistry; most were variations on familiar shampoo, conditioner, and treatment formats. Olaplex was founded by Dean Christal around a patented bond-rebuilding chemistry developed by chemists Eric Pressly and Craig Hawker. The technology claimed to repair the disulfide bonds in hair damaged by bleaching, coloring, and chemical processing. The product was genuinely chemically novel, not just a marketing claim. ## The salon-first launch Olaplex launched in 2014 exclusively through professional hair salons. The strategy was deliberate: - **Stylists were the proof point.** Professional hairdressers could see immediately whether the technology worked in their chairs. Bleaching previously-damaged hair without Olaplex versus with Olaplex produced visibly different outcomes. - **Stylist evangelism scaled the brand.** Stylists who saw the technology work became advocates, recommending it to other stylists at trade shows, on Instagram, and through professional networks. - **Trade-show and educational investment.** Olaplex invested heavily in professional education — classes, demonstrations, certifications — that brought the brand into stylist routines. - **Retail came later.** No. 3 Hair Perfector (the take-home version) launched at retail around 2017, after the professional channel had established the brand's credibility. Retail expansion benefited from stylist-driven word of mouth. ## What grew, and what came with it Olaplex grew significantly through 2014-2021 with the professional-first then retail-second strategy. The 2021 IPO valued the company at over $14 billion, making it one of the largest beauty IPOs ever. The post-IPO chapter has been brutal. The stock has lost over 90% of its peak value by 2024. Multiple factors contributed: - Category saturation. Competitors (K18, Living Proof, drugstore alternatives) entered the bond-rebuilding space with their own products, eroding Olaplex's differentiation. - Distribution disruption. Olaplex's professional channel was disrupted as more stylists used alternative products and the brand's exclusivity premium decreased. - Lawsuits and safety claims. A class-action lawsuit (later largely dismissed but ongoing in modified forms) alleged hair-loss and other safety issues with certain Olaplex products. The reputation impact was significant. - Growth deceleration. The brand's revenue growth slowed faster than the pre-IPO trajectory had suggested, leading to multiple downward earnings revisions and stock declines. ## How RGM thinks about pro-first launches and IPO valuation When clients in beauty or haircare ask about professional-first launch strategies, the Olaplex case is the structural model. The conditions: a product chemistry differentiated enough that professionals can verify it in their work (not just marketing claims), willingness to invest in professional education before retail, and patience to let stylist evangelism build credibility before retail expansion. The harder lesson is about IPO timing and post-IPO realities. Olaplex IPO'd at a $14B valuation during a beauty-IPO wave (Honest Co., Beauty Counter, etc.) that didn't hold up. The post-IPO stock collapse reflects both Olaplex-specific challenges and broader beauty-IPO valuation re-rating. We tell clients that IPO timing matters more than IPO valuation — pricing at the top of a category wave usually produces post-IPO challenges that take years to recover from, even when the underlying business is real. ## Frequently asked questions What does Olaplex actually do? The patented chemistry (Bis-Aminopropyl Diglycol Dimaleate) is claimed to rebuild disulfide bonds in hair that have been broken by bleaching, coloring, and chemical processing. Whether the chemistry produces meaningful long-term results has been the subject of professional debate, but the immediate visible effect on processed hair is widely accepted. What were the safety lawsuits about? A class-action lawsuit alleged that certain Olaplex products caused hair loss and other adverse effects. The lawsuit has gone through multiple stages including dismissal of certain claims; ongoing related litigation continues. The litigation has been a meaningful contributor to the post-IPO brand-equity damage and stock decline. Is Olaplex still leading the bond-builder category? Less than it was. Competitors (K18 especially, with its alternative peptide-based bond-building approach) have taken meaningful share. Olaplex remains a credible brand and a category-defining one historically, but the structural leadership position has narrowed as the category has matured. ### Sources & references - [Olaplex investor relations (OLPX)](https://ir.olaplex.com/) — SEC filings and quarterly reports. - [Olaplex (company site)](https://olaplex.com/) — Product and brand reference. - [Olaplex S-1 (2021)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001868726) — IPO filing. ## Related [#### All case studies The full case-study library.](/learn/case-studies/)[#### Glossier Different DTC beauty model with its own post-peak challenges.](/learn/case-studies/glossier-community-first/)[#### Allbirds Another DTC IPO that didn't hold up.](/learn/case-studies/allbirds-dtc-to-retail/)